Dantrolene Capsules and Ranibizumab ophthalmic
Determining the interaction of Dantrolene Capsules and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dantrolene
Brand name: Dantrium, Dantrium Intravenous, Revonto, Ryanodex
Synonyms: Dantrolene
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dantrolene Capsules-Ranitidine
- Dantrolene Capsules-Ranitidine Capsule
- Dantrolene Capsules-Ranitidine Hydrochloride
- Dantrolene Capsules-Ranitidine Injection
- Dantrolene Capsules-Ranitidine Suspension
- Dantrolene Capsules-Ranitidine Syrup
- Ranibizumab ophthalmic-Dantrolene Injection
- Ranibizumab ophthalmic-Dantrolene Intravenous
- Ranibizumab ophthalmic-Dantrolene Sodium
- Ranibizumab ophthalmic-Dapagliflozin
- Ranibizumab ophthalmic-Dapagliflozin and metformin
- Ranibizumab ophthalmic-Dapagliflozin and Metformin Extended-Release Tablets